CATX
Perspective Therapeutics Inc
Description:
Perspective Therapeutics Inc. (CATX) is a pioneering biotechnology firm focused on revolutionizing cancer care through the development of innovative radiopharmaceuticals. Leveraging state-of-the-art radioisotope technologies, CATX seeks to enhance the precision and effectiveness of cancer therapies, aiming to significantly improve patient survival rates across various malignancies. Backed by a seasoned leadership team and strong strategic alliances, the company is strategically positioned to drive advancements in targeted cancer treatments, addressing significant healthcare challenges in a competitive landscape.
Industry:
MEDICAL DEVICES
Address:
2401 ELLIOTT AVENUE, SEATTLE, WA, UNITED STATES, 98121
Fiscal year end:
December
Market capitalization:
$474 Million
Dividend per share:
$0.00
How much was you spent on shares:
$1,000
How much will you earn in
10 years:
-66%
How much will you get:
$339
Prices dates:
29-04-2016: $11.50 and 30-04-2026: $3.90